Novartis AG
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 35.5% | 35.5% | 18.2% |
| FY2022 | 11.7% | 11.7% | 5.9% |
| FY2023 | 31.8% | 31.8% | 14.9% |
| FY2024 | 27.1% | 27.1% | 11.7% |
| FY2025 | 30.3% | 30.3% | 12.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 35.5% | 35.5% | 18.2% |
| FY2022 | 11.7% | 11.7% | 5.9% |
| FY2023 | 31.8% | 31.8% | 14.9% |
| FY2024 | 27.1% | 27.1% | 11.7% |
| FY2025 | 30.3% | 30.3% | 12.6% |